Works matching DE "GLUCAGON-like peptides"
Results: 427
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 9, doi. 10.1007/s10557-024-07630-9
- By:
- Publication type:
- Article
Expression of a glucagon-like peptide-1 analogue, as a therapeutic agent for type II diabetes, with enhanced bioactivity and increased N-terminal homogeneity in Pichia pastoris.
- Published in:
- Biotechnology Letters, 2015, v. 37, n. 11, p. 2229, doi. 10.1007/s10529-015-1900-7
- By:
- Publication type:
- Article
Postconditioning with glucagon like peptide-2 reduces ischemia/reperfusion injury in isolated rat hearts: role of survival kinases and mitochondrial K channels.
- Published in:
- Basic Research in Cardiology, 2012, v. 107, n. 4, p. 1, doi. 10.1007/s00395-012-0272-6
- By:
- Publication type:
- Article
Does Glp-2 have a protective effect on cerebral ischemia/reperfusion model?
- Published in:
- Turkish Journal of Medical Sciences, 2015, v. 45, n. 3, p. 467, doi. 10.3906/sag-1402-64
- By:
- Publication type:
- Article
Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies Treatment.
- Published in:
- Movement Disorders Clinical Practice, 2018, v. 5, n. 3, p. 255, doi. 10.1002/mdc3.12611
- By:
- Publication type:
- Article
Combined training and hormones/enzymes with insulinotropic actions in individuals with overweight and type 2 diabetes mellitus: A randomized controlled trial.
- Published in:
- European Journal of Sport Science, 2024, v. 24, n. 1, p. 97, doi. 10.1002/ejsc.12057
- By:
- Publication type:
- Article
Highlights from the 58<sup>th</sup> Annual Meeting of the European Association for the Study of Diabetes.
- Published in:
- Diabetes & Primary Care, 2022, v. 24, n. 5, p. 151
- Publication type:
- Article
Does weight loss come at a cost in type 2 diabetes?
- Published in:
- Diabetes & Primary Care, 2022, v. 24, n. 2, p. 57
- By:
- Publication type:
- Article
News from the Diabetes UK Professional Conference 2021. Part 2.
- Published in:
- Diabetes & Primary Care, 2021, v. 23, n. 3, p. 83
- Publication type:
- Article
The 2019 ESC/EASD guidelines: Comprehensive and controversial.
- Published in:
- Diabetes & Primary Care, 2019, v. 21, n. 5, p. 145
- By:
- Publication type:
- Article
Statins, safety studies and sharing good practice.
- Published in:
- Diabetes & Primary Care, 2016, v. 18, n. 5, p. 202
- By:
- Publication type:
- Article
GLP-1 receptor agonist and basal insulin co-therapy in type 2 diabetes: Clinical evidence and practicalities of use.
- Published in:
- Diabetes & Primary Care, 2015, v. 17, n. 2, p. 80
- By:
- Publication type:
- Article
Glucose‐lowering drugs and liver‐related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population‐based studies.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 11, p. 1, doi. 10.1111/dme.15437
- By:
- Publication type:
- Article
Pancreatic polypeptide: A potential biomarker of glucose‐dependent insulinotropic polypeptide receptor activation in vivo.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 8, p. 1, doi. 10.1111/dme.14592
- By:
- Publication type:
- Article
Treating latent autoimmune diabetes in adults in the era of cardiovascular outcomes trials: Old dog should learn new tricks.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 3, p. 1, doi. 10.1111/dme.14496
- By:
- Publication type:
- Article
Update on technologies, medicines and treatments including Libre 3, Minimed 780G and Glucomen Day continuous glucose monitoring.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 1, p. 1, doi. 10.1111/dme.14451
- By:
- Publication type:
- Article
Clinical care and other categories posters: Incretin therapies.
- Published in:
- Diabetic Medicine, 2020, v. 37, p. 131, doi. 10.1111/dme.36_14245
- Publication type:
- Article
Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 2, p. 256, doi. 10.1111/dme.14094
- By:
- Publication type:
- Article
Differential increments of basal glucagon-like-1 peptide concentration among SLC47A1 rs2289669 genotypes were associated with inter-individual variability in glycaemic response to metformin in Chinese people with newly diagnosed Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 7, p. 987, doi. 10.1111/dme.13351
- By:
- Publication type:
- Article
Guidelines for managing diabetes in Ramadan.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 10, p. 1315, doi. 10.1111/dme.13080
- By:
- Publication type:
- Article
GLP-1-based diabetes therapies; trial by media.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 10, p. 1147, doi. 10.1111/dme.12299
- By:
- Publication type:
- Article
Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 1, p. 109, doi. 10.1111/dme.12003
- By:
- Publication type:
- Article
Indium-111-labeled CD166-targeted peptide as a potential nuclear imaging agent for detecting colorectal cancer stem-like cells in a xenograft mouse model.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-0597-3
- By:
- Publication type:
- Article
Commentary: a comparison of glucagon-like peptides 1 and 2.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 2, p. 279, doi. 10.1111/apt.12165
- By:
- Publication type:
- Article
Alveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 Therapy.
- Published in:
- Case Reports in Oncological Medicine, 2015, v. 2015, p. 1, doi. 10.1155/2015/107479
- By:
- Publication type:
- Article
Effect of ageing on colonic endocrine cell population in mouse.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Teduglutide: A Review in Short Bowel Syndrome.
- Published in:
- Drugs, 2017, v. 77, n. 3, p. 345, doi. 10.1007/s40265-017-0703-7
- By:
- Publication type:
- Article
Polymorphic amyloid nanostructures of hormone peptides involved in glucose homeostasis display reversible amyloid formation.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40294-x
- By:
- Publication type:
- Article
Brain Endothelial Cells Regulate Glucagon-Like Peptide 1 Entry Into the Brain via a Receptor-Mediated Process.
- Published in:
- Frontiers in Physiology, 2020, v. 11, p. 1, doi. 10.3389/fphys.2020.00555
- By:
- Publication type:
- Article
Dynamic Expression and Regulation of Urotensin I and Corticotropin-Releasing Hormone Receptors in Ovary of Olive Flounder Paralichthys olivaceus.
- Published in:
- Frontiers in Physiology, 2019, p. 1, doi. 10.3389/fphys.2019.01045
- By:
- Publication type:
- Article
Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.892677
- By:
- Publication type:
- Article
Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.892677
- By:
- Publication type:
- Article
Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 4, p. 733, doi. 10.1007/s13300-022-01231-1
- By:
- Publication type:
- Article
Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs).
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 8, p. 2133, doi. 10.1007/s13300-021-01113-y
- By:
- Publication type:
- Article
SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative Review.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 8, p. 2249, doi. 10.1007/s13300-021-01104-z
- By:
- Publication type:
- Article
Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 3, p. 1019, doi. 10.1007/s13300-019-0605-7
- By:
- Publication type:
- Article
DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson's Disease Rat Model.
- Published in:
- Parkinson's Disease (20420080), 2022, p. 1, doi. 10.1155/2022/1428817
- By:
- Publication type:
- Article
GLP-1 Gene-Modified Human Umbilical Cord Mesenchymal Stem Cell Line Improves Blood Glucose Level in Type 2 Diabetic Mice.
- Published in:
- Stem Cells International, 2019, p. 1, doi. 10.1155/2019/4961865
- By:
- Publication type:
- Article
Serum uromodulin is inversely associated with arterial hypertension and the vasoconstrictive prohormone CT-proET-1 in the population-based KORA F4 study.
- Published in:
- PLoS ONE, 2020, v. 15, n. 8, p. 1, doi. 10.1371/journal.pone.0237364
- By:
- Publication type:
- Article
Gewichtsabnahme ist mit Semaglutid signifikant grösser als mit Liraglutid.
- Published in:
- Praxis (16618157), 2022, v. 111, n. 9, p. 534, doi. 10.1024/1661-8157/a003839
- By:
- Publication type:
- Article
The central GLP-1: implications for food and drug reward.
- Published in:
- Frontiers in Neuroscience, 2013, v. 7, p. 1, doi. 10.3389/fnins.2013.00181
- By:
- Publication type:
- Article
New and Potential Treatments To Lengthen Life in Pediatric Short Bowel Syndrome.
- Published in:
- Pediatric Nursing, 2019, v. 45, n. 1, p. 23
- By:
- Publication type:
- Article
Invited Commentary: Go BIG and Go Global—Executing Large-Scale, Multisite Pharmacoepidemiologic Studies Using Real-World Data.
- Published in:
- American Journal of Epidemiology, 2022, v. 191, n. 8, p. 1368, doi. 10.1093/aje/kwac096
- By:
- Publication type:
- Article
Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Glucagon-like peptide-1 (7-37) augments insulin release in elderly patients with diabetes.
- Published in:
- 2001
- By:
- Publication type:
- Letter
Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Therapeutic effects of different doses of polyethylene glycosylated porcine glucagon-like peptide-2 on ulcerative colitis in male rats.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effects of new hypoglycemic drugs on cardiac remodeling: a systematic review and network meta-analysis.
- Published in:
- BMC Cardiovascular Disorders, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12872-023-03324-6
- By:
- Publication type:
- Article
Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1111, doi. 10.1007/s10557-020-07013-w
- By:
- Publication type:
- Article